Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | THRB | P10828 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 5/20 | 0.42 |
| ▸ | EGLN1 | Q9GZT9 | 2/20 | 0.42 |
| ▸ | ALKBH5 | Q6P6C2 | 1/20 | 0.42 |
| ▸ | SUCNR1 | Q9BXA5 | 1/20 | 0.42 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.41 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 2/20 | 0.36 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.36 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.36 |
| ▸ | ACLY | P53396 | 2/20 | 0.36 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.35 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.35 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.35 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.35 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25371748 | 0.84 | LMNA (0.48) | ALDH1A1KMT2AMEN1CYP1A2THRB | |
| SCHEMBL7416226 | 0.82 | LMNA (0.52) | ALDH1A1KMT2AMEN1THRBLMNA | |
| SCHEMBL28229868 | 0.80 | TSHR (0.55) | ALDH1A1KMT2AMEN1THRBLMNA | |
| SCHEMBL6283780 | 0.77 | LMNA (0.36) | ALDH1A1KMT2AMEN1CYP1A2THRB | |
| SCHEMBL12987414 | 0.77 | LMNA (0.47) | ALDH1A1KMT2AMEN1CYP1A2THRB | |
| SCHEMBL38157 | 0.77 | — | — | |
| SCHEMBL9437327 | 0.77 | LMNA (0.47) | ALDH1A1KMT2AMEN1CYP1A2THRB | |
| SCHEMBL27890788 | 0.77 | LMNA (0.47) | ALDH1A1KMT2AMEN1CYP1A2THRB | |
| Trifluoroacetic Acid SCHEMBL30548554 | 0.76 | ALDH1A1 (0.41) | ALDH1A1KMT2AMEN1CYP1A2THRB | |
| SCHEMBL23365242 | 0.76 | ALDH1A1 (0.41) | ALDH1A1KMT2AMEN1CYP1A2THRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116970337-B | Photo-curing self-repairing fluorine-silicon super-hydrophobic coating and preparation method and application thereof | 常州大学 | 2025-05-27 | — | — | CN | claimed |
| CN-113717055-B | Separation and purification method and system for 2-methyl-1, 2-propanediamine | 西安近代化学研究所 | 2024-03-26 | — | — | CN | claimed |
| CN-116970337-A | Photo-curing self-repairing fluorine-silicon super-hydrophobic coating and preparation method and application thereof | 常州大学 | 2023-10-31 | — | — | CN | claimed |
| CN-116444786-A | High-density fluorine-containing polyol and application thereof in dual self-repairing fluorine-containing polyurethane | 常州大学 | 2023-07-18 | — | — | CN | claimed |
| CN-114713044-B | Method for improving pollution resistance of composite nanofiltration membrane | 浙江理工大学 | 2023-05-05 | — | — | CN | claimed |
| CN-114713044-A | Method for improving anti-pollution performance of composite nanofiltration membrane | 浙江理工大学 | 2022-07-08 | — | — | CN | claimed |
| CN-113717055-A | Separation and purification method and system of 2-methyl-1, 2-propane diamine | 西安近代化学研究所 | 2021-11-30 | — | — | CN | claimed |
| EP-3618819-A1 | TARGETED DRUG RESCUE WITH NOVEL COMPOSITIONS, COMBINATIONS, AND METHODS THEREOF | Exciva GmbH (DE) | 2020-03-11 | — | — | EP | claimed |
| US-20200069674-A1 | TARGETED DRUG RESCUE WITH NOVEL COMPOSITIONS, COMBINATIONS, AND METHODS THEREOF | Exciva GmbH (DE) | 2020-03-05 | — | — | US | claimed |
| CN-110831584-A | Targeted drug rescue with novel compositions, combinations and methods thereof | 埃克塞瓦有限责任公司 | 2020-02-21 | — | — | CN | claimed |
| WO-2018204713-A1 | TARGETED DRUG RESCUE WITH NOVEL COMPOSITIONS, COMBINATIONS, AND METHODS THEREOF | EXCIVA UG (HAFTUNGSBESCHRÄNKT) (DE) | 2018-11-08 | — | — | WO | claimed |
| CN-116970337-B | Photo-curing self-repairing fluorine-silicon super-hydrophobic coating and preparation method and application thereof | 常州大学 | 2025-05-27 | — | — | CN | disclosed |
| CN-119954801-A | TAU protein targeting compounds and related methods of use | 阿尔维纳斯运营股份有限公司 | 2025-05-09 | — | — | CN | disclosed |
| CN-114867727-B | TAU protein targeting compounds and related methods of use | 阿尔维纳斯运营股份有限公司 | 2025-02-21 | — | — | CN | disclosed |
| CN-113717055-B | Separation and purification method and system for 2-methyl-1, 2-propanediamine | 西安近代化学研究所 | 2024-03-26 | — | — | CN | disclosed |
| US-4456768-A | Chemical synthesis | THE UNIVERSITY OF CHICAGO (US) | 1984-06-26 | — | — | US | disclosed |
| US-4324730-A | Certain fluorine substituted PGI2 compounds | THE UNIVERSITY OF CHICAGO (US) | 1982-04-13 | — | — | US | disclosed |
| EP-0037422-A4 | FLUORO-SUBSTITUTED PROSTAGLANDINS AND PROSTACYCLINS. | UNIV CHICAGO (US) | 1982-01-26 | — | — | EP | disclosed |
| EP-0037422-A1 | FLUORO-SUBSTITUTED PROSTAGLANDINS AND PROSTACYCLINS | UNIVERSITY OF CHICAGO (US) | 1981-10-14 | — | — | EP | disclosed |
| WO-1981001002-A1 | FLUORO-SUBSTITUTED PROSTAGLANDINS AND PROSTACYCLINS | UNIV CHICAGO (US) | 1981-04-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200069674-A1 | TARGETED DRUG RESCUE WITH NOVEL COMPOSITIONS, COMBINATIONS, AND METHODS THEREOF | HTR2A, HTR2C, CYP3A43 | ALDH1A1 235/4885KMT2A 1669/4885MEN1 3248/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.